Tuyac, Alqasim D.
HRN: 20-42-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2022
CEFTRIAXONE 1G (VIAL)
05/03/2022
05/09/2022
IV DRIP
800 Mg
OD
Bacterial Skin Infection, Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes